Wird geladen...
Enhancement of sialylation in rIgG in glyco-engineered Chinese hamster ovary cells
Since about 70% of commercial biopharmaceutical products have been produced in Chinese hamster ovary (CHO) cells, this cell line is undeniably a workhorse for biopharmaceuticals production. Meanwhile, sialic acid terminals were reported to affect anti-inflammatory activity, antibody-dependent cellul...
Gespeichert in:
| Veröffentlicht in: | Cytotechnology |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer Netherlands
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7225233/ https://ncbi.nlm.nih.gov/pubmed/32125558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10616-020-00381-z |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|